Sponsor: 
Merck Sharp & Dohme (Australia)
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use from birth.

Recombinant hepatitis B vaccine

Adult formulation

Each 1.0 mL monodose vial or pre-filled syringe contains:

  • 10 µg recombinant hepatitis B surface antigen (HBsAg) protein, adsorbed onto 0.5 mg aluminium hydroxide

Paediatric formulation

Each 0.5 mL monodose vial or pre-filled syringe contains:

  • 5 µg recombinant HBsAg protein, adsorbed onto 0.25 mg aluminium hydroxide

Dialysis formulation

Each 1.0 mL monodose vial contains:

  • 40 µg recombinant HBsAg protein, adsorbed onto 0.5 mg aluminium hydroxide

All formulations contain latex and may contain yeast proteins.

For full details, refer to the product information and consumer medicine information sheets for H-B-Vax II vaccine available on the TGA website.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018

Definitions

HBsAg
hepatitis B surface antigen